CD33 and neoplasm: Considering the mean quantile of expression versus other probes, surface markers CD64, CD1D, CD14, CD33, CD8A, CD16b, CD45 maintain a low level in cell lines versus microdissected tumor (all lower than the 35th quantile, p).